monoclonal antibody therapy

envie a um amigo share this

Conversation with James Allison from the JCI series «Conversations with Giants in Medicine»

We decided to republish in ASPIC's website the interview below:

 

 

Interview with James Allison of the MD Anderson Cancer Center, who has made key discoveries on the regulation of T cell activation and modulation. He was awarded the 2015 Lasker DeBakey Clinical Medical Research Award in honor of his discovery and subsequent development of CTLA-4–targeted monoclonal antibody therapy to unleash the immune response to cancer.

 

See the interview here: http://www.jci.org/videos/104

Conversation with James Allison from the JCI series «Conversations with Giants in Medicine»

We decided to republish in ASPIC's website the interview below:

 

 

Interview with James Allison of the MD Anderson Cancer Center, who has made key discoveries on the regulation of T cell activation and modulation. He was awarded the 2015 Lasker DeBakey Clinical Medical Research Award in honor of his discovery and subsequent development of CTLA-4–targeted monoclonal antibody therapy to unleash the immune response to cancer.

 

See the interview here: http://www.jci.org/videos/104